Skip to main content
OpenTrials

Clinical trial condition

Hypogonadism

Explore clinical trials studying Hypogonadism. Study availability and eligibility vary by location and protocol.

248 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Hypogonadism trial results

Completed

A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels

NCT01419236

Conditions
Ejaculatory Dysfunction, Endocrine System Diseases, Erectile Dysfunction, +9 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Diego, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Orleans, Louisiana, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brookline, Massachusetts, United States
View Trial Details
Completed

The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel

NCT01893281

Conditions
Endocrine System Diseases, Gonadal Disorders, Hypogonadism
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Encinitas, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Diego, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Parker, Colorado, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gainesville, Georgia, United States
View all 21 locations
View Trial Details
Completed

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

NCT01993225

Conditions
Endocrine System Diseases, Gonadal Disorders, Hypogonadism, +1 more
Locations
  • Birmingham, Alabama, United States
  • Mobile, Alabama, United States
  • Evanston, Illinois, United States
  • Lexington, Kentucky, United States
View Trial Details
Completed

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

NCT01993212

Conditions
Endocrine System Diseases, Gonadal Disorders, Hypogonadism, +1 more
Locations
  • Jacksonville, Florida, United States
  • Albany, New York, United States
  • Raleigh, North Carolina, United States
  • Cleveland, Ohio, United States
View Trial Details
Completed

Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism

NCT01270841

Conditions
Endocrine System Diseases, Gonadal Disorders, Hypogonadism, +1 more
Locations
  • Paradigm Clinical Inc. Garden Grove, California, United States
  • Northern California Research Corp Sacramento, California, United States
  • Medical Center for Clinical Research San Diego, California, United States
  • Los Angeles Biomedical Research Institute Torrance, California, United States
View all 18 locations
View Trial Details
Completed

Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

NCT01534208

Conditions
Endocrine System Diseases, Gonadal Disorders, Hypogonadism, +1 more
Locations
  • Clinical Research Advantage Glendale, Arizona, United States
  • Clinical Research Advantage Phoenix, Arizona, United States
  • Baptist Health Center for Clinical Research Little Rock, Arkansas, United States
  • Catalina Research Institute Chino, California, United States
View all 31 locations
View Trial Details

Related conditions